A detailed knowledge of the molecular architecture of immune receptors such as FcRL3 is crucial both for advancing our understanding of immune system function and for guiding the development of targeted therapeutic strategies for autoimmune disease. This evidence concerns the gene FCRL3 and autoimmune disease.